YDO1

Madrigal Pharmaceuticals Inc

YDO1.SG·Stuttgart

FollowCompareShare

402.10+2.60 (+0.65%)today

As of Oct 19, 11:16 AM CEST · May be delayed up to 15 min · EUR

1D5D1M6MYTD1Y5Y10Y20YAll

MountainLineCandles

Indicators

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close399.50

Open398.60

Day range398.30402.10

52-week range350.90519.60

Off day high0.00%

Off 52-week high−22.61%

Volume0.00

Avg. volume (3M)3.00

Market cap—

EPS (TTM)—

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)—

Shares outstanding—

Short interest—

Earnings dateJul 30, 2026

Analyst target—

Profit margin—

Related companies

Compare ›

Moves togetherAlso watched

The stocks whose daily moves over the past year went most closely with Madrigal Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
YDO1Madrigal Pharmaceuticals Inc. RYDO1.F · Correlation 0.66	9.21B	398.60	−0.42%

What visitors to Madrigal Pharmaceuticals's page also look at.

Company	Mkt cap	Price	Today
YDO1Madrigal Pharmaceuticals Inc. RYDO1.F	9.21B	398.60	−0.42%
EDLMEdel SE & Co. KGaAEDL.MU	—	4.6000	0.00%
EDLDEdel SE & Co. KGaAEDL.DU	—	4.5800	−0.43%
L41ALos Andes Copper Ltd.L41A.MU	—	7.55	0.00%
PATOPATO_PATO CHEMICAL INDUSTRYPATO-R.BK	—	6.15	0.00%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All YDO1.SG news ›

The Black Chronicle·4d ago

McCormick highlights research funding while touring Madrigal Pharmaceuticals

The Black Chronicle (The Center Square) – U.S. Sen. Dave McCormick, R-Pa., emphasized the importance of funding the National Institute of Health, NIH, and what role he sees Pennsylvania playing in the future of life sciences during a […]…

GlobeNewswire News Room·3d ago

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 15, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that…

Markets Daily·6d ago

Madrigal Pharmaceuticals (NASDAQ:MDGL) & MacroGenics (NASDAQ:MGNX) Head-To-Head Survey

Posted by Sarita Garza on Oct 12th, 2026 MacroGenics (NASDAQ:MGNX – Get Free Report) and Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two…

Madrigal Pharmaceuticals·Oct 10

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

Second Quarter 2026 and Recent Corporate Updates As disease awareness improves and disease prevalence increases, the number of diagnosed patients with F2 to F4c MASH is growing. Madrigal may use its website to comply with its disclosure…

From articles in the 4Search news index.

In the news

10mentions in 30 days

10with it in the headline

Positivesentiment

Mentioned with

Google5Sanofi5Merck Research Laboratories4National Institutes of Health4Pfizer4Astrazeneca3Instagram3LinkedIn3

People in the coverage

Donald Trump4ED Silverman4Pharmalittle4Pharmalot4Adam Steensberg3Christina Sonnenborg Bredal3

Themes

Cancer5Oncodaily5Oncology5Pharma5Pharmalittle5Biotechnology4Stat+4Earnings3

Most coverage from

1. biobuzz.io1
2. blackchronicle.com1
3. broadandliberty.com1
4. defenseworld.net1
5. globenewswire.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.